Her-2/neu (ErbB2) oncogene, the second member of the epidermal growth factor receptor (EGFR) family, encodes a transmembrane tyrosine kinase receptor in Her-2-positive tumors. Accumulating evidences demonstrate that signaling networks activated by EGFR and transcription factor NFjB are associated with cell response to ionizing radiation (IR). The present study shows that overexpression of ErbB2 enhanced NF-jB activation induced by IR in human breast carcinoma MCF-7 cells transfected with ErbB2 genes (MCF-7/ErbB2). Stable transfection of dominantnegative mutant IjB (MCF-7/ErbB2/mIjB) or treatment with anti-ErbB2 antibody, Herceptin, inhibited NF-jB activation and radiosensitized MCF-7/ErbB2 cells. Consistent with NF-jB regulation, basal and IR-induced Akt, a kinase downstream of ErbB2, was activated in MCF-7/ ErbB2 cells and inhibited by Herceptin. To identify specific genes affected by ErbB2-mediated NF-jB activation, a group of IR-responsive elements Cyclin B1, Cyclin D1, Bcl-2, Bcl/XL, BAD and BAX were evaluated. Basal levels of prosurvival elements Cyclin B1, Cyclin D1, Bcl-2 and Bcl/XL but not apoptotic BAD and BAX were upregulated in MCF-7/ErbB2 cells with striking enhancements in Bcl-2 and Bcl/XL. IR further induced Cyclin B1 and Cyclin D1 expression that was reduced by Herceptin. Bcl-2 kept a high steady level after Herceptin þ IR treatment and, in contrast to control MCF-7/Vector cells, Bcl/XL was inhibited in MCF-7/ErbB2 cells by Herceptin þ IR treatment. However, all four prosurvival proteins were downregulated by inhibition of NF-jB in MCF-7/ErbB2/mIjB cells. These results thus provide evidence suggesting that overexpression of ErbB2 is able to enhance NF-jB response to IR, and that a specific prosurvival network downstream of NF-jB is triggered by treatments using anti-ErbB2 antibody combined with radiation.
Introduction
Nuclear factor kappaB (NF-kB) was first identified as a protein bound to a sequence in the immunoglobulin kappa light chain enhancer in B cells stimulated with lipopolysaccharide (Sen and Baltimore, 1986) . This dimeric transcription factor is composed of different members of the Rel family -p65 (RelA), p50, p52, c-Rel and RelB (Baeuerle and Baltimore, 1996; Barkett and Gilmore, 1999) -which can activate a great variety of genes involved in stress responses, inflammation and programmed cell death (apoptosis) (Baeuerle and Baltimore, 1996) . Numerous experiments indicate that NF-kB is actively involved in the signaling network of apoptotic/ antiapoptotic responses induced by ionizing radiation (IR) and oxidative stress (Baldwin, 1996; Barkett and Gilmore, 1999; Gius et al., 1999; Granville et al., 2000; Bradbury et al., 2001; Kurland and Meyn, 2001; Ravi et al., 2001; McBride et al., 2002) . With binding sites found in the gene control region of about 150 stress-responsive effector genes, the major function of NF-kB activation is believed to reduce the apoptotic process via activation of antiapoptosis genes (Barkett and Gilmore, 1999) .
NF-kB has also been a transcription factor sensitive to IR-induced cell damage (Brach et al., 1991; Hallahan et al., 1998; Li and Karin, 1998; Beetz et al., 2000; Bradbury et al., 2001) . Treatment of IR activates IKK, the protein kinase that phosphorylates IkB-a at Ser-32 and Ser-36 (Li and Karin, 1998) , which in turn activates NF-kB nuclear translocation. Inhibition of IkB-a phosphorylation, which blocks IkB-a disassociation from p65/ p50 complexes, downregulates NF-kB and sensitizes cells to DNA-damaging agents (Miyakoshi and Yagi, 2000) . Many other results demonstrate that inhibition of NF-kB function increases cell radiosensitivity (Shao et al., 1997; Lee et al., 1998; Herscher et al., 1999; Yang et al., 1999; Kato et al., 2000) . We have reported that NF-kB activity is induced by radiation in breast carcinoma MCF-7 cells ) and virus-transformed human keratinocytes (Chen et al., 2002) . Gene clustering analyses demonstrate that at least a fraction of IR-inducible genes involved in signaling radioresistant phenotype is due to NF-kB activation (Guo et al., 2003) . Blocking NF-kB activity by dominant-negative mutant IkB transfection or indomethacin increases radiosensitivity and reduces or eliminates the expression of radioresistant genes (Bradbury et al., 2001; Li et al., 2001; Chen et al., 2002; Locke et al., 2002; Guo et al., 2003) .
Searching for potential genetic targets in gene and radiation therapy (Lammering et al., 2001a, b) , EGFR family members have been intensively studied in signaling radiation response and radioresistance (Schmidt-Ullrich et al., 1996; Schmidt-Ullrich et al., 1997) . Expression of ErbB2, a member of EGFR family that shows an ability to induce cell immortalization and transformation (Hayman and Enrietto, 1991; Labudda et al., 1995; Sherman et al., 1999) , is also demonstrated to induce tumor resistance to anticancer therapies (Slamon et al., 1987; Slamon, 1990; Cogswell et al., 2000; Bowers et al., 2001) . Overexpression of ErbB2 increases cell proliferation and survival (Kurokawa and Arteaga, 2001 ) that causes NF-kB activation (Galang et al., 1996; Raziuddin et al., 1997) . Importantly, PI3 kinase is found to be involved in Ras-enhanced radioresistance (Gupta et al., 2001) and PI3K/Akt pathways are activated by overexpression of ErbB2 (Pianetti et al., 2001; Stoica et al., 2003) . Recently, it is shown that blocking PI3K/Akt increases radiosensitivity (Liang et al., 2003) . In addition, Akt-mediated NF-kB activation has been identified to cause antiapoptosis in ErbB2-expresing cells (Yang et al., 2000) . Conversely, blocking ErbB2 by anti-ErbB2 antibodies provides direct evidence indicating that expression of ErbB2 induces radioresistance (Pegram et al., 1998; Pegram and Slamon, 2000) . For instance, combination of IR and anti-ErbB2 antibody demonstrated a synergistic tumor regression (Pietras et al., 1999; Schmidt et al., 2001) . It was assumed that this combined therapy could reduce the ability to repair DNA damage in tumor cells induced by IR (Pietras et al., 1999) . Indeed, strikingly as high as 40% of DNA-damage repair for cisplatinadducts is inhibited by chemotherapy combined with antiErbB2 antibody (Pietras et al., 1994) . These results strongly suggest that IR-induced stress signaling network be required for ErbB2-mediated radioresistance.
Using a pair of MCF-7 cells with or without ErbB2 expression, the present study was conducted to show that activation of NF-kB is causally related to ErbB2-mediated radioresistance. To determine the downstream signaling effectors, a group of IR-responsive genes, Cyclin B1, Cyclin D1, Bcl-2, Bcl/XL, BAD and BAX, were analysed, which showed a predominant enhancement in Bcl-2 and Bcl/XL expression. Although blocking NF-kB via mutant IkB transfection inhibited or reduced all the ErbB2-responsive genes, anti-ErbB2 antibody Herceptin combined with IR specifically inhibited Bcl/XL and Cyclin B1 and radiosensitized MCF-7/ErbB2 cells. These results thus suggest that specific IR-responsive genes regulated by NF-kB are required for ErbB2-mediated radioresistance.
Results

MCF-7/ErbB2 cells are resistant to IR with increased clonogenic survival and reduced apoptosis
MCF-7 cells overexpressing ErbB2 (MCF-7/ErbB2) vs MCF-7/Vector showed increased resistance to the cytotoxic effects of radiation. A decreased radiosensitivity in MCF-7/ErbB2 cells was demonstrated with an enhanced clonogenic survival (dose-modifying factor, DMF ¼ 1.85 at 10% isosurvival level, Figure 1a ). Apoptotic cells were measured in MCF-7/Vector vs MCF-7/ErbB2 cells before and after radiation with a single dose of 5 Gy. Although there was no obvious difference in the basal apoptosis (i.e. without IR, Figure 1b) , IR-induced apoptotic cells, especially in the detached cells, showed a significant decrease (50% at 48 h) in MCF-7/ErbB2 cells (Figure 1b and c) compared to the vector control cells. These results indicate an enhanced radioresistant phenotype in MCF-7 cells by overexpressing ErbB2. However, although our data showed an agreement between the decreased apoptotic cells and increased clonogenic survival, we cannot exclude the possibility that apoptosis-independent cell death (e.g. necrosis and mitosis-linked cell death) may also contribute to the radioresistant phenotype observed in MCF-7/ErbB2 cells.
Superinduction of NF-kB in MCF-7/ErbB2 cells after IR
To determine that NF-kB is specifically activated in MCF-7/ErbB2 cells, NF-kB and AP-1 (included as a control) luciferase reporters were transfected and luciferase activity was analysed in MCF-7/Vector and MCF-7/ErbB2 cells (Figure 2a ). Compared to AP-1-controlled luciferase activity that showed no differences, the basal NF-kB-controlled luciferase activity was elevated in MCF-7/ErbB2 cells (Figure 2a ). In addition, a time-course analysis further demonstrated that NF-kB transcriptional activity was induced in MCF-7/ErbB2 cells to a greater extent than MCF-7/ Vector cells after radiation with a single dose of 5 Gy (42-fold that induced in MCF-7/Vector cells, Figure 2b ).
Inhibition of NF-kB with mutant IkB radiosensitized MCF-7/ErbB2 cells
We hypothesized that ErbB2-induced radioresistance is causally related to NF-kB activation. To test this hypothesis, we transfected MCF-7/ErbB2 cells with the dominant-negative mutant IkB that has been shown to inhibit NF-kB nuclear translocation (Rice and Ernst, 1993) . Figure 2c shows that in contrast to empty vector transfected MCF-7/ErbB2/Vector cells, both basal and IR-induced NF-kB activities were significantly inhibited in MCF-7/ErbB2/mIkB cells. The radiosensitivity measured by clonogenic survival (Figure 2d ) was significantly diminished in MCF-7/ ErbB2/mIkB cells compared to the vector control MCF-7/ErbB2/Vector cells. The clonogenic survival of MCF-7/ErbB2/mIkB cells irradiated in the dose range of 0-4 Gy was similar to the level of parent control MCF-7/Vector cells (shown in Figure 1a ), suggesting that NF-kB activation is an essential event in ErbB2-mediated radioresistance.
Herceptin inhibited NF-kB, increased IR-induced apoptosis and radiosensitized MCF-7/ErbB2 cells We then determined if blocking ErbB2 by anti-ErbB2 antibody Herceptin, which is known to enhance radiosensitivity, operates by inhibiting radiation-induced NFkB activity in MCF-7/ErbB2 cells. Figure 3a shows that radiation plus Herceptin increased apoptosis in MCF-7/ ErbB2 cells twofold and fourfold compared to that, respectively, with radiation or Herceptin alone. However, although Herceptin pretreatment showed an increase in apoptotic cells, no significant alteration was detected in clonogenic survival and NF-kB induction without radiation (data not shown). In contrast, pretreatment of MCF-7/ErbB2 cells with Herceptin for 4 h before radiation significantly increased the clonogenic radiosensitivity (Figure 3b ). In addition, Herceptin pretreatment almost totally abolished radiation-induced NF-kB activity (86%, 200 mM and 102%, 400 mM, Figure 3c ). These results demonstrate that ErbB2-mediated radioresistance is related to NF-kB activation induced by IR.
Akt was activated in MCF-7/ErbB2 and inhibited by Herceptin
Akt activation has been shown to play a key role in NFkB activation and antiapoptosis (Madrid et al., 2000) . To determine if radiation-induced ErbB2/NF-kB activation is mediated by Akt, we measured the Akt protein kinase activity in MCF/ErbB2 and MCF-7/Vector cells with or without IR or Herceptin. Like NF-kB, the basal Akt activity was elevated by ErbB2 expression and IR further induced p-Akt activity in MCF-7/ErbB2 cells compared to the control MCF-7/Vector cells ( Figure 4a ). Similar to as NF-kB inhibition induced by Herceptin treatment (Figure 3c ), Herceptin blocked the basal and radiation-induced p-Akt activity in MCF-7/ErbB2 cells. However, total Akt proteins (Akt1) did not change (Figure 4b ), suggesting that both constitutive and radiation-induced p-Akt activities are caused by phosphorylation of Akt that may be activated due to NF-kB activation. NF-jB in ErbB2-mediated radioresistance G Guo et al
Increased basal protein levels of Cyclin B1, Cyclin D1, Bcl-2 and Bcl/Xl but not BAD or BAX in MCF-7/ErbB2 cells
We have shown that a group of radiation-responsive genes including Cyclin B1, Cyclin D1, Bcl-2 and Bcl/XL were upregulated together with NF-kB activation in radioresistant cells derived from multiples exposure to IR Chen et al., 2002; Guo et al., 2003) .
To investigate whether the ErbB2-mediated radioresistance is associated with the expression of radiationresponsive genes due to NF-kB activation, we determined the constitutive protein levels of Cyclin B1, Cyclin D1, Bcl-2, Bcl/XL, BAD and BAX in MCF-7/ Vector and MCF-7/ErbB2 cells. Compared to the control MCF-7/Vector cells, proteins of radiationresponsive prosurvival (Cyclin B1, Cyclin D1, Bcl-2 and Bcl/XL) but not proapoptotic (BAD and BAX) signaling elements were maintained at a higher level in MCF-7/ErbB2 cells ( Figure 5 ).
Different response of Bcl-2 and Bcl/XL to Herceptin and radiation
Next , Luciferase and b-galactosidase activities were determined 6 h after 5 Gy IR and relative transcriptional activity was presented as the luciferase activity normalized to b-galactosidase (mean7s.e., n ¼ 3; **Po0.01). (b) Time-course analysis of IR-induced NF-kB activity in MCF-7/Vector and MCF-7/ErbB2 cells. Luciferase reporters of NFkB were cotransfected with b-galactosidase reporter into control MCF-7/Vector and MCF-ErbB2 cells and luciferase activity was determined and normalized to b-galactosidase at indicated times after 5 Gy IR (mean7s.e., n ¼ 3; *Po0.05, **Po0.01). (c) IR-induced NFkB luciferase activity was inhibited in MCF-7/ErbB2/mIkB cells. NFkB luciferase and b-galactosidase reporters were cotransfected into MCF-7/ErbB2/mIkB and vector control MCF-7/ErbB2/Vector cells and luciferase and b-galactosidase activities were determined 24 h after 5 Gy IR (mean7s.e., n ¼ 3; **Po0.01). (d) Clonogenic survival of MCF-7/ErbB2/mIkB vs MCF-7/ErbB2/Vector cells. Different cell numbers of MCF-7/ErbB2/mIkB and MCF-7/ErbB2/Vector cells were plated into T25 flask and exposed to a range of IR doses (0-4 Gy). Clonogenic survival was determined 18 days after IR. Colonies with more than 50 cells were counted and survival fractions of each cell line were normalized to the plating efficiency (mean7s.e.; n ¼ 3)
induced radiosensitization. However, Herceptin or Herceptin þ IR significantly inhibited ErbB-2-induced Bcl/XL expression in MCF-7/ErbB2 cells ( Figure 6a and b, lanes 7-12). As a result, the ratio of (Figure 6a , lanes 1-6).
Inhibition of prosurvival elements in MCF-7/ErbB2/mIkB cells Finally, we determined if blocking NF-kB activity by the dominant-negative mutant IkB inhibits radiationresponsive genes that are responsive to Herceptin treatment in MCF-7/ErbB2 cells. Figure 7 shows that in contrast to Herceptin-induced specific inhibition of Bcl/XL and Cyclin B1 (shown in Figure 6 ), expression levels of Cyclin B1, Cyclin D1, Bcl-2 and Bcl/XL but not NF-jB in ErbB2-mediated radioresistance G Guo et al the control Actin were generally downregulated 40-60% in MCF-7/ErbB2/mIkB cells with or without IR. Therefore, although both Herceptin and mutant IkB transfection inhibited NF-kB activity and increased the radiosensitivity in MCF-7/ErbB2 cells, Herceptin appears to regulate IR-induced prosurvival signaling elements Cyclin B1, Cyclin D1 and Bcl/XL in MCF-7/ ErbB2 cells (compared to Figure 6 ).
Discussion
These findings provide the evidence indicating that ErbB2-mediated radioresistance requires the activation of NF-kB signaling network. In results similar to the dominant-negative IkB that blocks NF-kB nuclear translocation, anti-ErbB2 antibody Herceptin blocked the basal and radiation-induced Akt and NF-kB activity and caused radiosensitization. Among a group of IRresponsive genes including Cyclin B1, Cyclin D1, Bcl-2 and Bcl/XL, overexpression of ErbB2 induced a high expression of Bcl-2 and Bcl/XL. However, unlike mutant IkB that inhibited all IR-responsive genes tested, pretreatment of Herceptin inhibited IR-induced Cyclin B1 and Bcl/XL but not Bcl-2, conferring a change in the ratio of Bcl/XL : Bcl-2. Thus, signaling elements, Akt, NF-kB, Bcl/XL and Cyclin B1, appear to be specifically associated with ErbB2-mediated radioresistance. Accumulating evidence indicates that transcription factor NF-kB is a sensor protein to radiation-induced stress responses (Beetz et al., 2000; Bradbury et al., 2001) . Although genotoxic agents, including IR, evidently activate NF-kB function, the molecular mechanism causing NF-kB activation under different stress conditions has not been identified. IKK, the protein kinase that phosphorylates IkB-a, has been shown to accelerate NF-kB nuclear translocation (Li and Karin, NF-jB in ErbB2-mediated radioresistance G Guo et al 1998), and inhibition of IkB-a phosphorylation is able to block NF-kB activation and sensitize tumor cells to DNA-damaging agents including IR (Shao et al., 1997; Lee et al., 1998; Miyakoshi and Yagi, 2000; Chen et al., 2002) . Although NF-kB is activated in many cells that do not express EGFR family protein ErbB2 (Shao et al., 1997; Li et al., 2001; Guo et al., 2003) , the present results demonstrate that overexpression of ErbB2 accelerates IR-induced NF-kB activation and that ErbB2-induced radioresistant phenotype is causally related to NF-kB signaling network. PI3K activity has been shown to play a key role in radioresistance (Gupta et al., 2001) . Interestingly, overexpression of ErbB2 activates PI3K (Hermanto et al., 2001) and PI3K, in turn, activates Akt kinase and NFkB (Pianetti et al., 2001) , causing enhanced anchorageindependent growth of ErbB2-overexpressing cancer cells (Gupta et al., 2001; Hermanto et al., 2001) . Following this line of reasoning, activation of PI3K/Akt pathway mediated by ErbB2 expression must be involved in IR-induced NF-kB activation that regulates downstream effector genes required for ErbB2-mediated radioresistance. Recent data (Contessa et al., 2002) further identified that Akt activation by IR was dependent on ErbB2 function. The present study demonstrated that, notably, about 200-400% of both Akt and NF-kB activities was detected in MCF-7/ErbB2 cells compared to the control MCF-7/Vector cells (Figures 2 and 4 ). It is therefore highly possible that Akt functions as an IR-sensitive element to activate NFkB network causing radioresistance in cells expressing ErbB2. This ErbB2-mediated pathway seems to be specific, since NF-kB but not AP-1 (Figure 2a ) was activated in MCF-7/ErbB2 cells.
Many other results have evidently demonstrated that ErbB2 expression alters tumor response to chemo-and radiotherapy. However, key signaling elements in ErbB2-mediated tumor resistance have not been identified. We conducted the present study to try to verify if radioresistant effector genes responsive to NF-kB activation are associated with ErbB2 overexpression. A specific group of IR-responsive signaling proteins encoded by genes upregulated in the gene expression profiles of irradiated cells (Fornace et al., 1999; Li et al., 2001; Guo et al., 2003) was analysed in cells with ErbB2 expression and treated with anti-ErbB2 antibody Herceptin and IR. These IR-inducible signaling proteins including Cyclin B1, Cyclin D1, Bcl-2 and Bcl/XL have been shown to be responsive to NF-kB regulation (Chen et al., 2002; Guo et al., 2003) . The most significant finding, though, is the enhancement of constitutive protein levels of Bcl-2 and Bcl/XL in MCF-7/ErbB2 cells, both of which were strikingly low in ErbB2-negative control cells, suggesting an antiapoptotic pathway of ErbB2-mediated prosurvival network. However, although Bcl-2 and Bcl/XL have been well defined to function in antiapoptosis against many anticancer agents (Miyake et al., 1998; Ravi and Bedi, 2002) , Bcl/ XL is not linked with the antiapoptosis to TNF-ainduced apoptosis that is dependent on NF-kB-induced expression of manganese-containing superoxide dismutase (MnSOD) (Delhalle et al., 2002) . Interestingly, the expression of Bcl/XL in the present study is obviously reversed by treatments of Herceptin or Herceptin þ IR in control and MCF-7/ErbB2 cells (Figure 6 ). Herceptin induced Bcl/XL expression in the control and MCF-7/ ErbB2 cells as well as Cyclin B1 expression in MCF-7/ ErbB2 cells. Herceptin inhibited Bcl/Xl expression, and Herceptin þ IR significantly inhibited both Bcl/XL and Cyclin B1. In contrast, little change was detected in Bcl-2 expression. This pattern of prosurvival signaling elements strongly suggests that among the ErbB2 upregulated IR-responsive effector genes, Bcl/XL and Cyclin B1 are targets of the combined treatment of antiErbB2 antibody and radiation.
Altered cell cycle control may directly increase ErbB2-mediated radioresistance. Cyclin B1 is documented to function as a rate-limiting component for the transition of cells going from G2 to M and a determinant in apoptosis (Taylor and Stark, 2001) . Cyclin B1 is able to form a complex with Cdc2 (Taylor and Stark, 2001) and patched1 (ptc1), a tumor suppressor associated with basal cell carcinoma (Barnes et al., 2001) to adjust the rate of cell cycle progression. In addition, Cyclin B1 and the phosphorylated Cdc2 are activated by oxidative stress to regulate cell cycle control (Zhang et al., 2001) . From a gene expression profile of MCF-7 breast cancer cells treated with IR, upregulated Cyclin B1 was found to be one of the essential elements for IR-induced radioresistance in MCF-7 cells . Recently, intensive studies have revealed ErbB2-mediated resistance to anticancer agent-induced apoptosis. Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1 that inhibits Cdc2 kinase. Another experiment using Herceptin pretreatment in ErbB2-overexpressing breast cancer cells showed an enhanced sensitivity to Taxol-induced apoptosis . It is believed that the resistance to Taxol is caused by phosphorylation in tyrosine-15 of Cdc2 by ErbB2 expression, resulting in inhibition of Cdc2-and Taxol-induced apoptosis (Tan et al., 2002) . p27(Kip1), a cyclin-dependent kinase inhibitor, is also downregulated by ErbB2 expression (Yang et al., 2000) . In contrast to the ErbB2-mediated Cdc2 inhibition that offered Taxol resistance, the present study shows that Cyclin B1, which forms complexes with Cdc2, was maintained in MCF-7/ErbB2 cells and Cyclin B1 was further increased after radiation. Pretreatment of Herceptin inhibited IR-induced Cyclin B1, indicating that Cyclin B1 is a key element in ErbB2-mediated radioresistance. Therefore, Cyclin B1/Cdc2 pathways appear to be differentially regulated in ErbB2-mediated cell resistance to Taxol or IR. We have previously reported that pretreatment with antisense oligonucleotides of Cyclin B1 gene increases radiosensitivity of MCF-7 cells . Clinically, expression of Cyclin B1 has been indicated as an important factor when evaluating radioresistance of patients with squamous cell carcinoma (Soria et al., 2000; Hassan et al., 2001) and those with regional recurrence of head and neck tumors treated by radiotherapy (Hassan et al., 2002) . Together with ErbB2-induced activation of Bcl-2 and Bcl/Xl, our results demonstrate a tight regulation of Cyclin B1 linked with the prosurvival network in ErbB2-overexpresing cells. In contrast to the specific inhibition of Bcl/XL induced by Herceptin treatment, all the IR-responsive genes tested were downregulated in MCF-7/ErbB2/ mIkB cells that showed inhibition of NF-kB and increased radiosensitivity. Thus, apparently, Herceptin pretreatment that actually inhibits NF-kB and causes radiosensitization, affects not all IR-inducible genes that are responsive to NF-kB activation. Recent data have shown that different components of NF-kB subunits can induce or inhibit gene expression (Daosukho et al., 2002) and, as a result, activites pathways of pro-or antiapoptotic responses (Zhou et al., 2001; Bernard et al., 2002; Grdina et al., 2002) . Therefore, NF-kB subunits activated by IR in ErbB2-overexpressing cells may be alternatively different from those induced by IR in ErbB2-negative cells such as control MCF-7/Vector cells. In support of this concept, Bcl/XL and Cyclin B1, both of which are responsive to NF-kB activation, are differentially regulated by Herceptin and Herceptin þ IR treatments in MCF-7/ErbB2 and MCF-7/ Vector cells. Since Herceptin pretreatment significantly affects Bcl/XL but not Bcl-2 expression, specific inhibition of the non-Herceptin-responsive Bcl-2 in ErbB2-positive tumor cells may promise a potential to further enhance the radiosensitivity induced by anti-ErbB2 antibodies.
In conclusion, these findings demonstrate that ErbB2-mediated radioresistance requires NF-kB activation. Akt appears to be an important mediator for ErbB2-enhanced NF-kB activation. Pretreatment with Herceptin or transfection of the dominant-negative mutant IkB inhibites IR-induced NF-kB activity resulting in an increased radiosensitivity. A group of prosurvival genes are induced by ErbB2 expression whereas Bcl/Xl and Cyclin B1 are inhibited by Herceptin pretreatment combined with IR. Thus, Akt, NF-kB, Bcl/XL and Cyclin B1 are suggested to play an active role in ErbB2-mediated radioresistance.
Materials and methods
Clonogenic survival to ionizing radiation
Human breast carcinoma MCF-7 cells that overexpress c-erbB-2 gene (MCF-7/ErbB2) and vector control (MCF-7/ Vector) were kindly provided by Dr Slamon at the University of California Los Angeles. Both MCF-7/ErbB2 and MCF-7/ Vector cells were routinely cultured as per the published procedure in DMEM supplemented with 10% heat-inactivated fetal bovine serum, 2 mM freshly added glutamine, and 1% penicillin G-streptomycin-fungizone solution (Irvine Scientific, Santa Ana, CA, USA). Radiosensitivity was assessed by clonogenic survival following exposure to a range of doses of IR. The irradiated and control cells were cultured for 18 days and clones with more than 50 cells were scored. Herceptin (humanized anti-ErbB2 antibody) was purchased from Genentech Inc. Cell survival was assessed by colony formation following exposure for 12 h to 200 and 400 mM of Herceptin followed by a range of doses of IR. The irradiated cells were cultured at 371C with 5% CO 2 for 21 days and clones with more than 50 cells were scored and normalized to the survival fractions of control MCF-7/Vector cells.
Determining IR-induced apoptosis
Terminal deoxynucleotidyltransferase-mediated UTP end labeling (TUNEL) method was used to detect apoptotic cells. Briefly, Cells with or without 5 Gy IR were incubated at 371C and at times after IR both attached and floating cells were harvested and mixed. After washing with PBS, cells were dropped on to slide glasses and dried with cold air. All the cells were fixed for 30 min at room temperature with 4% paraformaldehyde PBS. The slides were coded and evaluated using the Â 40 objective with a photomicrography rectangle. To obtain a mean number for the presence of positive in up to 2000 cells for each experimental data point, at least 10 fields were evaluated in each slide. The fraction of apoptotic cells was expressed as the ratio of the total number of cells and was determined in three independent experiments for each time point.
Reporter transfection and luciferase assay NF-kB and AP-1 luciferase reporters and gene transfection were the same as described before . Briefly, MCF-7/ErbB2 and MCF-7/Vector cells grown in 12-well plates were cotransfected with 0.3 mg luciferase transcription factor reporters and 0.2 mg b-galactosidase reporters for 3 h, then irradiated or sham-irradiated at room temperature with 5 Gy, and luciferase activity was measured at different times following radiation. For normalization of the reporter transfection efficiency, an aliquot of the same cell lysate was saved for measurement of b-galactosidase activity.
Akt enzyme activity
MCF-7/Vector and MCF-7/ErbB2 cells were irradiated with 5 Gy with or without Herceptin treatment. Cell lysates were prepared 24 h after radiation. Cells were then washed and lysed with the lysis buffer provided in the Bio-Rad Cell Lysis Kit by following the user manual. Protein concentration was measured with DC TM Protein Assay Kit (Bio-Rad Laboratories) and protein concentration was adjusted using the cell lysis buffer. P-Akt was measured using the Bio-Plext Phosphoprotein Assay (Bio-Rad Laboratories). The filter plate was rinsed with 100 ml phosphoprotein wash buffer, followed by the addition of 50 ml of anti-Akt conjugated beads, 25 ml of each cell lysate, and 25 ml of phosphoprotein assay buffer. The plate was shaken overnight and incubated with biotinylated antiphospho-Akt (Ser473) antibody. P-Akt was then determined by incubation with 50 ml of streptavidin-labeled phycoerythrin (PE) and read on the Bio-Plex t system.
Establishment of MCF/ErbB2/mIkB transfectants
MCF-7/ErbB2 cells were stably transfected with dominantnegative mutant IkB genes and stable transfectants were obtained using LipofectAMINE reagent (Life Technologies, Inc.) as previously described (Chen et al., 2002) . MCF-7/ ErbB2 cells (5 Â 10 6 in 100 mm cell culture dishes) were transfected with 15 mg mutant IkB plasmid controlled by a CMV promoter, 2 mg hygromycin marker DNA pCEP4 and 40 mg LipofectAMINE in 6 ml serum-reduced OPTI-EMEM (Life Technologies, Inc.). pcDNA3 in place of mutant IkB was cotransfected into MCF-7/ErbB2 cells as a vector control. Cells were transfected with transfection solution for 72 h and recovered for 24 h in complete medium, trypsinized and cultured in the selecting medium with 80 mg/ml hygromycin B for 21 days. The selected mutant IkB (MCF-7/ErbB2/mIkB) and vector control clones (MCF-7/ErbB2/Vector) were maintained in DMEM with 20 mg/ml hygromycin B. NF-kB inhibition was confirmed in MCF-7/ErbB2/mIkB vs MCF/ ErbB2/Vector cells, and both cell lines were cultured for at least two passages in hygromycin B-free medium before experiments.
Western blot
Cells were collected from the culture T75 flasks and washed with PBS and lysed on ice for 10 min in 1.5 ml of lysis buffer per flask (10 mM HEPES, 10 mM KCl, 1.5 mM MgCl 2 , 0.5 mM DTT, 1% NP-40, PMSF 1 mM, 25% glycerol and 0.2 mM EDTA). Protein concentrations were determined using the Protein Assay Kit (Pierce, Rockford, IL, USA). Equal aliquots of protein (20 mg) were electrophoresed through 12% SDSpolyacrylamide gels after boiling for 5 min in Laemmli sample buffer. Proteins were then transferred to Nitrocellulose membranes (BioRad, Hercules, CA, USA) and blocked in 0.1% Tween 20 blocking buffer containing 5% nonfat dry milk. Membranes were then blotted with the appropriate primary antibodies at the dilution 1 : 200-800. They were then incubated with horseradish peroxidase-conjugated secondary antibody at a dilution of 1 : 3000. Blotted proteins were visualized using the ECL þ Plus Western blotting detection system (Amersham Life Science, Arlington Heights, IL, USA). Colored markers (BioRad, Hercules, CA, USA) were used as molecular size standards.
Statistics
Data analysis was performed using STATMOST32 software. Time-series effects were evaluated by analysis of variance and differences between values within a single series by StudentNewman-Keuls test. Differences between pairs of data for the same time point were analysed by F test followed by either paired t-test or Mann-Whitney test.
Abbreviations IR, ionizing radiation; NF-kB, nuclear factor kappaB; ROS, reactive oxygen species; TNF, tumor necrosis factor.
